Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies

Research output: Contribution to journalArticle

11 Citations (Scopus)
88 Downloads (Pure)

Search results